Refined Risk Stratification in Cholangiocarcinoma Resection
Anatomic and biologic criteria improve recurrence predictions post-surgery for perihilar cholangiocarcinoma, enhancing patient selection.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
Bevacizumab strategies enhance surgical options in liver metastases
Patients with initially unresectable colorectal liver metastases benefit from certain induction therapies that increase surgical conversion potential.
Molecular insights reshape cholangiocarcinoma surgery.
Tailoring surgical strategies based on molecular profiles can improve outcomes in cholangiocarcinoma patients.
Palliative Care’s Impact on End-of-Life Procedures in HPB Cancer
Incorporating palliative care can significantly impact procedural decisions for patients with hepatopancreatobiliary cancers.
Evolving Insights on Splenectomy for Hematologic Malignancies
Splenectomy shows variable success across indications in hematologic cancers.
Lymph node burden predicts recurrence patterns in cholangiocarcinoma
Tumor features after surgery for intrahepatic cholangiocarcinoma can inform recurrence risk and patient outcomes.
Neoadjuvant Therapy Improves Survival After Intrahepatic Cholangiocarcinoma Resection
Neoadjuvant therapy may significantly enhance post-recurrence survival in patients with intrahepatic cholangiocarcinoma.
Examining Age Impacts Survival in Intrahepatic Cholangiocarcinoma
Younger patients with intrahepatic cholangiocarcinoma (IHC) show significantly better outcomes when unresectable compared to older patients, which may influence surgical decision-making.
Surgeons See 10-Year Survival in Resection of Liver Metastases
Resection of solitary colorectal liver metastases leads to excellent long-term survival, but outcomes depend on lymph node status and tumor size.
Angioembolization Equals Survival to Surgery in Liver Trauma
Angioembolization offers equivalent survival rates compared to surgery for penetrating liver trauma but leads to longer hospital stays.